TrialHIV medicine2015

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

A Carr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.